Stiplastics Unveils New Dosing Spoon at CPhI
Spoonbox is now available in a 13-mL format for dosing products in liquid form and micro-granules.
Stiplastics, a company specializing in the design and development of innovative injected plastic-based medical devices, has unveiled a new 13-mL Spoonbox dosing spoon at CPhI Worldwide 2015. According to Stiplastics, the new dosing spoon was developed in response to pharmaceutical laboratories requesting a device that has greater capacity than that of the 8-mL and 9-mL versions.
The Spoonbox product offers an alternative to the pipette in terms of economics, hygiene, and ergonomics. Quality and reliability are attributes of the product, says the company, along with the decorative options, which include pad-printing, to bring an element of fun to the task of taking medication, particularly where children are concerned.
Stiplastics has carried out validation work, which means that Spoonbox can also be used to measure micro-granules. Laboratory Lucane Pharma, for example, has chosen it for a micro-granule product designed to treat a rare disease.
Source: Stiplastics, 4C110
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy
April 28th 2025Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
